Prefrontal FGF1 Signaling is Required for Accumbal Deep Brain Stimulation Treatment of Addiction
Advanced Science · 2025-04 · 12 (16)
DOI: 10.1002/advs.202413370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.02.2025. Verfasst von Wan-Kun Gong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai…. Hauptthemen laut MEDLINE: Nucleus Accumbens, Prefrontal Cortex, Fibroblast Growth Factor 1, Deep Brain Stimulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Commission of Health, China Postdoctoral Science Foundation.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Deep brain stimulation (DBS) has emerged as a prospective treatment for psychiatric disorders; for example, DBS targeting the nucleus accumbens (NAc) abolishes addictive behaviors. However, neither the core pathway nor the cellular mechanisms underlying these therapeutic effects are known. Here, morphine‐induced conditioned place preference (CPP) in mice as an addiction model and NAc‐DBS combined with adeno‐associated virus gene delivery for activity‐dependent tagging, transgenic and chemogenetic manipulation of recruited neuronal networks are used. It is reported that a cortical‐accumbal pathway and local fibroblast growth factor 1 (FGF1) signaling in the medial prefrontal cortex (mPFC) are critical for NAc‐DBS to be effective in altering morphine CPP. It is shown that NAc‐DBS retrogradely activates mPFC neurons projecting to the NAc, and chemogenetic activation/inhibition of these DBS‐activated neuron ensembles in the mPFC reproduces the NAc‐DBS effects on CPP. Sustained therapeutic effects accompany reductions in local FGF1 binding to fibroblast growth factor receptor 1 (FGFR1) in these neurons. Additionally, overexpressing FGF1 in the mPFC‐NAc pathway abolishes the therapeutic effects of NAc‐DBS. These results demonstrate that the mPFC‐NAc pathway forms a top‐down motif to regulate the therapeutic effects of subcortical DBS on addiction. These results support the potential for addiction treatments involving FGF1 signaling and highlight the mPFC as a target for noninvasive brain stimulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine and School of Psychology, Shan…
- Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, 226019, China.
- Department of Clinical Laboratory Diagnosis, Changhai Hospital, Shanghai, 200433, China.
- Institute of Mental Health and Drug Discovery, Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine Vision and Brain Health), School of Mental Health, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
- Institut de Neurosciences de la Timone, UMR7289 CNRS & Aix-Marseille Université, Marseille, France.
- Shenzhen Key Laboratory of Smart Healthcare Engineering, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, China.
ORCID-Profile: Wan-Kun Gong, Ti-Fei Yuan
Förderung
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Commission of Health
- China Postdoctoral Science Foundation
- International Science and Technology Cooperation Programme
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
- Major Research Plan
- Shanghai Municipal Education Commission
- National Natural Science Foundation of China
Zitieren
APA
Gong, W. K., Li, X., Wang, L., Yang, Q., Tiran-Cappello, A., Liang, Z., Samsom, J., Liu, Q., Lin, H., Baunez, C., Liu, F., & Yuan, T. F. (2025). Prefrontal FGF1 Signaling is Required for Accumbal Deep Brain Stimulation Treatment of Addiction. Advanced Science, 12(16). https://doi.org/10.1002/advs.202413370
Vancouver
Gong WK, Li X, Wang L, Yang Q, Tiran-Cappello A, Liang Z, et al. Prefrontal FGF1 Signaling is Required for Accumbal Deep Brain Stimulation Treatment of Addiction. Advanced Science. 2025;12(16). doi:10.1002/advs.202413370
BibTeX
@article{Gong2025,
author = {Gong, Wan-Kun and Li, Xue and Wang, Le and Yang, Qian and Tiran-Cappello, Alix and Liang, Zhichao and Samsom, James and Liu, Quanying and Lin, He and Baunez, Christelle and Liu, Fang and Yuan, Ti-Fei},
title = {Prefrontal FGF1 Signaling is Required for Accumbal Deep Brain Stimulation Treatment of Addiction},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {16},
doi = {10.1002/advs.202413370}
}
EUVIMED